The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 934-940

  Kloppenburg, Margreet ^a   Brinkman, Brigitta M N ^a   De Rooij Dijk, Henny H ^a   Miltenburg, André M M ^a   Daha, Mohamed R ^a   Breedveld, Ferdinand C ^a   Dijkmans, Ben A C ^a   Verweij, Cornelis L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALCIUM IONOPHORE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MINOCYCLINE; TETRACYCLINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MESSENGER RNA SYNTHESIS; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029867083     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.934     Document Type: Article

References (51)

1. Aarden, L. A., M. Helle, L. Boeije, and D. Pascual-Salcedo. 1991. Differential induction of interleukin-6 production in monocytes, endothelial cells and smooth muscle cells. Eur. Cytokine Network 2:115-120.
2. Albert, A., and C. W. Rees. 1956. Avidity of the tetracyclines for the cations of metals. Nature (London) 177:433-434.
3. Banck, G., and A. Forsgren. 1979. Antibiotics and suppression of lymphocyte function in vitro. Antimicrob. Agents Cremother. 16:554-560
4. 2+ receptor" activation. Biosci. Rep. 13:169-174.
5. Beaty, C. D., T. L. Franklin, Y. Uehara, and C. B. Wilson. 1994. Lipopolysaccharide-induced cytokme production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction. Eur. J. Immunol. 24:1278-1284.
6. Bellahsene, A., and A. Forsgren. 1985. Effect of doxycycline on immune response in mice. Infect. Immun 48:556-559.
7. Bloemena, E., R. H. J. Van Oers, S. Weinreich, and P. T. A. Schellekens. 1989. The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro. Eur. J. Immunol 19:943-946.
8. Bouaboula, M., P. Legoux, B. Pességue, B. Delpech, X. Dumont, M. Piechaczyk, P. Casellas, and D. Shire. 1992. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control J. Biol Chem. 267:21830-21838.
9. Braegger, C. P., S. Nicholls, S. H. Murch, S. Stephen, and T. T. Macdonald. 1992. Tumor necrosis factor α in stool as a marker for intestinal inflammation Lancet 339:89-91.
10. Breedveld, F. C., B. A. C. Dijkmans, and H. Mattie. 1990. Minocycline treatment for rheumatoid arthritis: an open dose finding study. J. Rheumatol. 17:14-16.
11. Brennan, F. M., R. N. Maini, and M. Feldmann. 1992 TNF alpha - a pivotal role in rheumatoid arthritis. Br. J. Rheumatol. 31:293-298.
12. Cerami, A., and B. Beutler. 1988. The role of cachectin/TNF in endotoxic shock and cachexia Immunol Today 9:28-31
13. De Jonge, H. R. 1973. Toxicity of tetracyclines in rat-intestinal epithelium and liver. Biochem. Pharmacol. 22:2659-2677.
14. Derkx, B., J. Taminiau, S. A. Radema, A. Stronkhorst, C. Workel, G. N. J. Tytgat, and S. J. H. van Deventer. 1992. Tumor necrosis factor antibody treatment in Crohn's disease. Lancet 342:173-174.
15. Elliot, M. J., R. N. Maini, M. Feldmann, J. R. Kalden, C. Antoni, J. S. Smolen, B. Leeb, F. C. Breedveld, J. D. Macfarlane, H. Bijl, and J. N. Woody. 1994. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110.
16. Engelberts, L, A. Möller, G. J. M. Schoen, C. J. Van der Linden, and W. A. Buurman. 1991 Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res 10:133-140.
17. Feldmann, M., F. M. Brennan, D. Chantry, C. Haworth, M. Turner, E. Abney, G. Buchan, K. Barrett, D. Barkley, A. Chu, M. Field, and R. N. Maini. 1990 Cytokine production in the rheumatoid joint: implications for treatment. Ann. Rheum. Dis. 51:480-486.
18. Golub, L. M., H. M. Lee, G. Lehrer, A. Nemiroft, T. F. McNamara, R. Kaplan, and N. S. Ramamurthy. 1983. Minocycline reduces gingival collagenolytic activity during diabetes. J. Periodont. Res. 18:516-524.
19. Goodhart, G. L. 1979. Further evidence for the role of bivalent cations in human polymorphonuclear leukocyte locomotion: recovery from tetracycline-induced inhibition in the presence of cation ionophores. J. Reticuloendothelial Soc. 25:545-554.
20. Grau, G. E., L. F. Tajardo, P. F. Piguet, B. Allet, P. H. Lambert, and P. Vassali. 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria Science 237:1210-1212.
21. Greenwald, R. A., L. M. Golub, B. Lavietes, N. S. Ramamurthy, B. Gruber, R. S. Laskin, and T. F. McNamara. 1987. Tetracyclines inhibits human synovial collagenase in vivo and in vitro. J. Rheumatol. 14:28-32.
22. Helle, M., L. Boeije, E. De Groot, A. de Vos, and L. Aarden. 1991. Sensitive ELISA for interleukin-6. J. Immunol. Methods 138:47-56.
23. Humbert, P., P. Treffel, and J. F. Chapuis, et al. 1991. The tetracyclines in dermatology. J. Am. Acad Dermatol. 25:691-697.
24. Imboden, J. B., A. Weiss, and J. Stobo. 1985. The antigen receptor on a human T cell line initiates activation by increasing cytoplasmic free calcium. J Immunol. 134:663-665
25. Ingham, E. 1990. Modulation of the proliferative response of murine thymocytes stimulated by IL-1. and enhancement of IL-1β secretion from mononuclear phagocytes by tetracyclines. J. Antimicrob. Chemother. 26:61-70.
26. Ingham, E., L. Turnbull, and J. N, Kearney. 1991 The effects of minocyline and tetracycline on the mitotic response of human peripheral blood lymphocytes. J. Antimicrob. Chemother. 27:607-617.
27. Jaatella, M. 1991. Biology of disease: biologic activities and mechanisms of action of tumor necrosis factor alpha/cachectin. Lab. Invest 64:724-742
28. June, C, H., J. A. Ledbetter, M. H. Gilespie, T. Lindsten, and C. B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472-4481.
29. Kloppenburg, M., F. C. Breedveld, J. P. Terwiel, C. Mallee, and B. A. C. Dijkmans. 1994. Minocycline in active rheumatoid arthritis, a double-blind placebo-controlled trial Arthritis Rheum. 37:629-636
30. Kloppenburg, M., H. Mattie, W. Douwes, B. A. C. Dijkmans, and F. C. Breedveld. 1995. Minocycline in the treatment of rheumatoid arthritis: relationship of serum concentrations to efficacy. J. Rheumatol. 22:611-616.
31. Kloppenburg, M., C. L. Verweij, A. M. M. Miltenburg, A. J. Verhoeven, M. R. Daha, B. A. C. Dijkmans, and F. C. Breedveld. 1995. The influence of tetracyclines on T cell activation. Clin. Exp Immunol. 102:635-641.
32. Langevitz. P., D. Zemer, M. Book, and M. Pras. 1992. Treatment of resistant rheumatoid arthritis with minocycline: an open dose study. J. Rheumatol. 19:1502-1504.
33. Mandrup-Poulsen, T., K. Bendtnen, J. H. Nielsen, G. Bendixen, and J. Nerup, 1992. Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 40:424-429.
34. Novogrodsky, A, A. Vanichkin, M. Patya, N. Osherov, and A. Levitzki. 1994. Prevention of lipopolysaccharidc-induced lethal toxicity by tyrosine kinasc inhibitors. Science 264:1319-1322.
35. Potts, R. C., H. A. A. Hassan, R. A. Brown, A. MacConnachie, J. H. Gibbs, A. J. Robertson, and J. Swanson, 1983. In vitro effects of doxycycline and tetracycline on mitogen stimulated lymphocyte growth. Clin. Exp. Immunol 53:458-464.
36. Rijkers, G. T., A. G. Teunissen, R. van Oosterom, and W. B. van Muiswinkel. 1980. The immune system of cyprinid fish. The immunosuppressive effect of the antibiotic oxytetracycline in carp (Cyprinus carpio L.). Aquaculture 19: 177-189.
37. Rijkers, G. T., R. van Oosterom, and W. B. van Muiswinkel. 1981. The immune system of cyprinid fish. Oxytetracycline and the regulation of humoral immunity in carp (Cyprinus carpio). Vet. Immunol. Immunopathol. 2:281-290.
38. Roche, Y., M. Fay, and M.-A. Gougerot-Pocidalo. 1988. Interleukin-1 production by antibiotic-treated human monocytes J. Antimicrob. Chemother. 21:597-607.
39. Saivin, S., and G. Houin. 1988 Clinical pharmacokinetics of doxycycline and minocycline Clin. Pharmacokinet. 15:355-361.
40. Saxne, T, M. A. Palladino, D. Hewidegard, Jr, N. Talal, and F. A. Wollheim. 1988. Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum. 31:1041-1048.
41. Sewell, K. L., E. Furrie, and D. E. Trentham. 1990. The therapeutic effect of minocycline in experimental arthritis: mechanism of action. Arthritis Rheum 33(Suppl.):S106.
42. Thong, Y. H., and A. Ferrante. 1979. Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues Clin. Exp. Immunol. 35:443-446.
43. Thong, Y. H., and A. Ferrante. 1980. Effect of tetracycline treatment on immunological responses in mice. Clin. Exp Immunol. 39:728-732.
44. Tilley, B. C., G. S. Alarcon, S. P. Heyse, D. E. Trentham, R. Neuner, D. A. Kaplan, D. O. Clegg, J. C. C. Leisen, L. Buckley, S. M. Cooper, H. Duncan, S. R. Pillemer, M. Tuttleman, and S. E. Fowler. 1995. Minocycline in rheumatoid arthritis, a 48-week, double-blind, placebo-controlled trial. Ann. Intern. Med. 122:81-89.
45. Truneh, A., F. Albert, P. Golstein, and P. M. Schmitt-Verhulst. 1985. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature (London) 313:318-321.
46. Van den Bogert, C., B. H. J. Dontje, M. Holtrop, T. E. Melis, J. C. Romijn, J. W. van Dongen, and A. M. Kroom. 1986. Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis. Cancer Res. 46:3283-3289.
47. Van den Bogert, C., and A. M. Kroon. 1982. Effects of oxytetracycline on in vivo proliferation and differentiation on erythroid and lymphoid cells in the rat. Clin. Exp. Immunol. 50:327-335.
48. Van der Meide, P. H., M. Dubbeld, and H. Schellekens. 1985. Monoclonal antibodies to human interferon and their use in a sensitive solid-phase ELISA. J. Immunol. Methods 79:293-305.
49. Van Kooten, C., H. J. A. M. Rensink, P. Salceda, M. H. J. van Oers, and L. A. van Aarden. 1991. Monokine production by human T cells: interleukin-Iα production restricted ßïmemory T cells. J Immunol. 146:2654-2660.
50. Vilcek, J., and T. H. Lee. 1991. Tumor necrosis factor, new insights into the molecular mechanisms of its multiple actions. J. Biol Chem. 266:7313-7316.
51. Weiss, A., R. L. Wiskocil, and J. D. Stobo. 1984. The role of T3 surface molecules in the activation of human T cells: a Two-stimulus requirement for IL2 production reflects events occurring at a pre-translational level. J. Immunol. 133:123-128